CareRx Corporation
CHHHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $67 | $91 | $90 | $92 |
| % Growth | -26.8% | 2.1% | -2.9% | – |
| Cost of Goods Sold | $50 | $64 | $63 | $65 |
| Gross Profit | $17 | $27 | $27 | $27 |
| % Margin | 25.4% | 29.7% | 29.7% | 29.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $8 | $8 | $10 |
| SG&A Expenses | $15 | $8 | $8 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $17 | $16 | $18 |
| Operating Expenses | $15 | $25 | $25 | $27 |
| Operating Income | $2 | $2 | $2 | -$0 |
| % Margin | 3.6% | 2.5% | 2.2% | -0.1% |
| Other Income/Exp. Net | -$1 | -$2 | -$2 | -$2 |
| Pre-Tax Income | $1 | $1 | $0 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $0 | -$2 |
| % Margin | 1.7% | 0.6% | 0.3% | -2.4% |
| EPS | 0.018 | 0.009 | 0.004 | -0.037 |
| % Growth | 98.9% | 147.2% | 109.7% | – |
| EPS Diluted | 0.017 | 0.009 | 0.004 | -0.037 |
| Weighted Avg Shares Out | 63 | 63 | 63 | 60 |
| Weighted Avg Shares Out Dil | 65 | 65 | 65 | 60 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $2 | $2 | $2 |
| Depreciation & Amortization | $3 | $5 | $5 | $5 |
| EBITDA | $6 | $7 | $7 | $5 |
| % Margin | 8.3% | 7.5% | 7.6% | 5.4% |